Intuitive Surgical (ISRG) is making waves in the stock market, recently valued at approximately $163 billion and showing robust growth in its robotic surgical systems. The company reported a 19% year-over-year revenue increase to $2.9 billion, driven by an 18% rise in procedures performed with its da Vinci and Ion systems. Notably, the Ion procedures surged by 44%, indicating strong demand and market penetration, with over 12,000 systems installed globally.
Despite not paying dividends, Intuitive Surgical has engaged in share repurchases, enhancing shareholder value by reducing the number of outstanding shares. While the stock trades at a forward P/E ratio of 46—lower than its five-year average of 57—it remains relatively expensive. However, the potential for long-term growth, especially if the company begins paying dividends in the future, makes it an intriguing option for investors with a long-term horizon.
For market professionals, the key takeaway is that while ISRG may not be a bargain, its growth trajectory and market position suggest it could be a valuable addition to a long-term investment strategy. Consider building a position gradually to capitalize on its potential.
Source: fool.com